Keybanc analyst Josh Beck downgrades BTRS Holdings (NASDAQ:BTRS) from Overweight to Sector Weight.
GSK’s Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults
The European Commission has approved GSK plc's (NYSE: